Status:
COMPLETED
A Study of Anal Cancer Development in HIV Infected People
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
HIV Infections
Anus Neoplasms
Eligibility:
All Genders
13+ years
Brief Summary
The purpose of this study is to compare the development of abnormal cell growth or cancer in the anal region of individuals who are receiving one of two different anti-HIV treatment strategies.
Detailed Description
Human papillomavirus (HPV) is a common viral infection among men and women. Individuals with HPV are at risk for anal dysplasia, a condition that may lead to anal cancer. It has been observed that HIV...
Eligibility Criteria
Inclusion
- Coenrollment in the SMART study
- Normal anal cytology result. If baseline anal cytology is abnormal, high-resolution anoscopy must be performed and specimens must be obtained.
- Parent or guardian willing to provide informed consent, if applicable
Exclusion
- Current or prior history of anal or cervical cancer
- Permanent or irreversible bleeding disorder that would interfere with biopsy of the anal canal
Key Trial Info
Start Date :
February 1 2005
Trial Type :
OBSERVATIONAL
End Date :
March 1 2006
Estimated Enrollment :
560 Patients enrolled
Trial Details
Trial ID
NCT00107679
Start Date
February 1 2005
End Date
March 1 2006
Last Update
April 17 2014
Active Locations (13)
Enter a location and click search to find clinical trials sorted by distance.
1
LA Gay & Lesbian Community Service Ctr., Lamba Med. Group CRS
Los Angeles, California, United States, 90028
2
Castro-Mission Health Ctr. CRS
San Francisco, California, United States, 94114
3
Univ. of Colorado Health Science Ctr. CRS
Denver, Colorado, United States, 80204-4507
4
Eastside Family Health Ctr. CRS
Denver, Colorado, United States, 80205